Mineralys Therapeutics (MLYS) Enterprise Value (2023 - 2026)
Mineralys Therapeutics (MLYS) posted Enterprise Value of $1.6 billion for Q3 2026, down 33.4% from $2.4 billion a year earlier and down 7.1% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Enterprise Value (2023 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Enterprise Value at Mineralys Therapeutics was -$364.03 million; for FY2025, it came in at $1.8 billion, up 333.3% from FY2024.
- In prior years, Mineralys Therapeutics' Enterprise Value was $415.12 million in FY2024 (+254.2%) and $117.18 million in FY2023.
- Quarterly Enterprise Value has run from a low of $117.17 million in Q1 2023 to a high of $2.4 billion in Q3 2025 over five years.
- On a year-over-year basis, Enterprise Value increased in seven of the last eight quarters, with growth averaging 219.9%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q3 2025, with growth of 608.4%; the weakest was Q2 2024, with a decline of 37.9%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $1.72 billion (Q2 2026), $1.59 billion (Q1 2026) and $1.8 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Mineralys Therapeutics | 1.42 Bn | -1.17 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.60 Bn |
| Jun 30, 2026 | 1.72 Bn |
| Mar 31, 2026 | 1.59 Bn |
| Dec 31, 2025 | 1.80 Bn |
| Sep 30, 2025 | 2.40 Bn |
| Jun 30, 2025 | 564.35 Mn |
| Mar 31, 2025 | 501.21 Mn |
| Dec 31, 2024 | 415.12 Mn |
| Sep 30, 2024 | 338.94 Mn |
| Jun 30, 2024 | 270.50 Mn |
| Mar 31, 2024 | 302.20 Mn |
| Dec 31, 2023 | 117.18 Mn |
| Sep 30, 2023 | 137.15 Mn |
| Jun 30, 2023 | 435.51 Mn |
| Mar 31, 2023 | 117.17 Mn |
API Access
Mineralys Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();